Amer Assal
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Hematology 17
- Hematopoietic Stem Cell Transplantation 9
- Acute Myeloid Leukemia Research 5
- Multiple Myeloma Research and Treatments 4
- Immunology 12
- Immune Cell Function and Interaction 7
- Immunotherapy and Immune Responses 4
- Co-authors
- Xingxing Zang (3 shared papers)Eszter Lázár‐Molnár (1 shared paper)Yu Yao (1 shared paper)Kim C. Ohaegbulam (1 shared paper)Markus Y. Mapara (14 shared papers)Murali Janakiram (6 shared papers)Gopichand Pendurti (1 shared paper)Alain Borczuk (1 shared paper)
- Journals
- Blood (7 papers)Biology of Blood and Marrow Transplantation (4 papers)Transplantation and Cellular Therapy (4 papers)Blood Coagulation & Fibrinolysis (2 papers)Frontiers in Immunology (2 papers)
- Partner nations
- United StatesSaudi ArabiaUnited Kingdom
In The Last Decade
Amer Assal
29 papers receiving 932 citations
Amer Assal's Hit Papers
Peers
Comparison fields: 5 of 81
- Oncology 591
- Immunology 433
- Hematology 84
- Pulmonary and Respiratory Medicine 157
- Cancer Research 66
Countries citing papers authored by Amer Assal
This map shows the geographic impact of Amer Assal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amer Assal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amer Assal more than expected).
Fields of papers citing papers by Amer Assal
This network shows the impact of papers produced by Amer Assal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amer Assal. The network helps show where Amer Assal may publish in the future.
Co-authors
The 25 scholars most cited alongside Amer Assal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway Hit paper breakdown → | 2014 | 654 |
| 2 | 2018 | 76 | |
| 3 | 2015 | 40 | |
| 4 | 2016 | 29 | |
| 5 | 2020 | 18 | |
| 6 | 2017 | 14 | |
| 7 | 2021 | 13 | |
| 8 | 2021 | 13 | |
| 9 | 2020 | 13 | |
| 10 | 2019 | 11 | |
| 11 | 2020 | 9 | |
| 12 | 2021 | 7 | |
| 13 | 2023 | 5 | |
| 14 | 2021 | 5 | |
| 15 | 2014 | 5 | |
| 16 | 2013 | 4 | |
| 17 | 2020 | 4 | |
| 18 | 2016 | 4 | |
| 19 | 2024 | 3 | |
| 20 | 2018 | 3 |
About Amer Assal
Amer Assal is a scholar working on Hematology, Immunology, Oncology, Infectious Diseases and Epidemiology, having authored 32 papers that have together received 941 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (9 papers), Immune Cell Function and Interaction (7 papers), Acute Myeloid Leukemia Research (5 papers), Immunotherapy and Immune Responses (4 papers), Multiple Myeloma Research and Treatments (4 papers), Cancer Treatment and Pharmacology (3 papers), Acute Lymphoblastic Leukemia research (3 papers) and Hematological disorders and diagnostics (3 papers). The work is most often cited by research in Oncology (591 citations), Immunology (433 citations), Hematology (84 citations), Pulmonary and Respiratory Medicine (157 citations) and Cancer Research (66 citations). Amer Assal has collaborated with scholars based in United States, Saudi Arabia and United Kingdom. Frequent co-authors include Xingxing Zang, Eszter Lázár‐Molnár, Yu Yao, Kim C. Ohaegbulam, Markus Y. Mapara, Murali Janakiram, Gopichand Pendurti, Alain Borczuk, Juan Lin and Haiying Cheng. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Transplantation and Cellular Therapy, Blood Coagulation & Fibrinolysis and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.